Related Experiment Video
Updated: Feb 20, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Unusual Complication of Multidrug Resistant Tuberculosis
Prerna Sharma1, Ravindra Nath Sahay1
1Division of Medicine, Seth G.S. Medical College & KEM Hospital, Parel, Mumbai 400 012, India.
Capreomycin, used for multidrug-resistant tuberculosis, can cause Bartter-like syndrome. This case highlights the importance of monitoring electrolytes during capreomycin treatment to prevent severe complications.
Area of Science:
- Nephrology
- Pharmacology
- Endocrinology
Background:
- Capreomycin is a second-line antitubercular agent.
- Aminoglycosides, including capreomycin, are known for potential nephrotoxicity.
- Multidrug-resistant tuberculosis necessitates the use of drugs like capreomycin.
Observation:
- A 23-year-old female developed carpopedal spasms and paresthesias.
- The patient was on capreomycin for two months for tuberculosis treatment.
- Laboratory findings revealed hypocalcemia, hypomagnesemia, hypokalemia, hyponatremia, and hypochloremic metabolic alkalosis with hypercalciuria.
Findings:
- Capreomycin treatment induced a Bartter-like syndrome.
- Electrolyte abnormalities and metabolic alkalosis were corrected upon capreomycin discontinuation and supplementation.
- Vitamin D and PTH levels were normal, ruling out primary endocrine causes.
Implications:
- Aminoglycoside-induced renal tubular dysfunction can manifest as Bartter-like syndrome.
- Prompt recognition and management of dyselectrolytemia are crucial in patients receiving aminoglycosides.
- This case underscores the need for vigilant monitoring of renal function and electrolytes.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Development of Antibiotic Resistance